Barbara Cannon
Barbara Cannon has joined the scientific and medical advisory board for Metabolic Solutions Development Company (MSDC).
Currently a professor of physiology at Stockholm University's Wenner-Gren Institute for Experimental Biology, Cannon is also president of the Royal Swedish Academy of Sciences.
In her new role she will work on the company’s insulin resistance and type 2 diabetes programs.
Stephen Benoit, MSDC's CEO, said of her appointment: “Her ground-breaking insights into brown fat metabolism will contribute significantly to the explanation of the mechanisms by which our novel insulin sensitizers improve insulin sensitivity in patients diagnosed with type 2 diabetes."